Randomized controlled trial of oral omega-3 PUFA in solar-simulated radiation-induced suppression of human cutaneous immune responses1-3

American Journal of Clinical Nutrition

Volumn 97, Issue 3, 2013, Pages 646-652

  Pilkington, Suzanne M ^a   Massey, Karen A ^b   Bennett, Susan P ^a   Al Aasswad, Naser M I ^b   Roshdy, Khaled ^a   Gibbs, Neil K ^a   Friedmann, Peter S ^c   Nicolaou, Anna ^b   Rhodes, Lesley E ^a,d  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d HOPE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; INTERLEUKIN 10; INTERLEUKIN 4; NICKEL; OMEGA 3 FATTY ACID; PROSTAGLANDIN E2;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CANCER RISK; CHEMOPROPHYLAXIS; CONTACT ALLERGY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; ERYTHROCYTE MEMBRANE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HORMONE SUBSTITUTION; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MEMBRANE FLUIDITY; NICKEL HYPERSENSITIVITY; PATCH TEST; PATIENT COMPLIANCE; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RADIATION; RANDOMIZED CONTROLLED TRIAL; SIGNAL TRANSDUCTION; SKIN CANCER; TUMOR PROMOTION;

ADULT; DERMATITIS, CONTACT; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; MIDDLE AGED; NICKEL; SKIN; SOLAR ENERGY; ULTRAVIOLET RAYS; YOUNG ADULT;

EID: 84874320224     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.112.049494     Document Type: Article

References (57)

1. Cancer Research UK. Sunlight and sunbeds and skin cancer in the UK-statistics. Version Current 9 December 2011. Available from: http://info.cancerresearchuk.org/cancerstats/causes/lifestyle/sunlight/ sunlightand-skin-cancer-in-the-uk#Incidence (cited 16 July 2012).
2. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, Coldiron BM. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010;146:283-7.
3. Kripke ML, Cox PA, Alas LG, Yarosh DB. Pyrimidine dimers in DNA initiate systemic immunosuppression in UV-irradiated mice. Proc Natl Acad Sci USA 1992;89:7516-20.
4. Noonan FP, De Fabo EC, Kripke ML. Suppression of contact hypersensitivity by UV radiation and its relationship to UV-induced suppression of tumor immunity. Photochem Photobiol 1981;34:683-9.
5. Kripke ML, Fisher MS. Immunologic responses of the autochthonous host against tumors induced by ultraviolet light. Adv Exp Med Biol 1976;66:445-9.
6. Schwarz T. Photoimmunosuppression. Photodermatol Photoimmunol Photomed 2002;18:141-5.
7. Jensen P, Hansen S, Møller B, Leivestad T, Pfeffer P, Geiran O, Fauchald P, Simonsen S. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999;40:177-86.
8. Hakim IA, Harris RB, Ritenbaugh C. Fat intake and risk of squamous cell carcinoma of the skin. Nutr Cancer 2000;36:155-62.
9. Kune GA, Bannerman S, Field B, Watson LF, Cleland H, Merenstein D, Vitetta L. Diet, alcohol, smoking, serum beta-carotene, and vitamin A in male nonmelanocytic skin cancer patients and controls. Nutr Cancer 1992;18:237-44.
10. Fischer MA, Black HS. Modification of membrane composition, eicosanoid metabolism, and immunoresponsiveness by dietary omega-3 and omega-6 fatty acid sources, modulators of ultraviolet-carcinogenesis. Photochem Photobiol 1991;54:381-7.
11. Black HS, Thornby JI, Gerguis J, Lenger W. Influence of dietary omega-6,-3 fatty acid sources on the initiation and promotion stages of photocarcinogenesis. Photochem Photobiol 1992;56:195-9.
12. Lou Y-R, Peng Q-Y, Li T, Medvecky CM, Lin Y, Shih WJ, Conney AH, Shapses S, Wagner GC, Lu Y-P. Effects of high-fat diets rich in either omega-3 or omega-6 fatty acids on UVB-induced skin carcinogenesis in SKH-1 mice. Carcinogenesis 2011;32:1078-84.
13. Orengo IF, Black HS, Kettler AH, Wolf JE Jr. Influence of dietary menhaden oil upon carcinogenesis and various cutaneous responses to ultraviolet radiation. Photochem Photobiol 1989;49:71-7.
14. Moison RM, Beijersbergen Van Henegouwen GM. Dietary eicosapentaenoic acid prevents systemic immunosuppression in mice induced by UVB radiation. Radiat Res 2001;156:36-44.
15. Rhodes LE, O'Farrell S, Jackson MJ, Friedmann PS. Dietary fish-oil supplementation in humans reduces UVB-erythemal sensitivity but increases epidermal lipid peroxidation. J Invest Dermatol 1994;103: 151-4.
16. Rhodes LE, Shahbakhti H, Azurdia RM, Moison RM, Steenwinkel MJ, Homburg MI, Dean MP, McArdle F, Beijersbergen van Henegouwen GM, Epe B, et al. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers. Carcinogenesis 2003;24:919-25.
17. Ziboh VA, Miller CC. Essential fatty acids and polyunsaturated fatty acids: significance in cutaneous biology. Annu Rev Nutr 1990;10: 433-50.
18. Reeve VE, Bosnic M, Boehm-Wilcox C. Dependence of photocarcinogenesis and photoimmunosuppression in the hairless mouse on dietary polyunsaturated fat. Cancer Lett 1996;108:271-9.
19. Becker D, Knop J. Mechanism in allergic contact dermatitis. Exp Dermatol 1993;2:63-9.
20. Damian DL, Barnetson RS, Halliday GM. Effects of low-dose ultraviolet radiation on in vivo human cutaneous recall responses. Australas J Dermatol 2001;42:161-7.
21. Sivapirabu G, Yiasemides E, Halliday GM, Park J, Damian DL. Topical nicotinamide modulates cellular energy metabolism and provides broad-spectrum protection against ultraviolet radiation-induced immunosuppression in humans. Br J Dermatol 2009;161:1357-64.
22. Damian DL, Halliday GM. Measurement of ultraviolet radiation-induced suppression of recall contact and delayed-type hypersensitivity in humans. Methods 2002;28:34-45.
23. Fedler R, Stromer K. Nickel sensitivity in atopics, psoriatics and healthy subjects. Contact Dermatitis 1993;29:65-9.
24. Fuchs J, Packer L. Antioxidant protection from solar-simulated radiation-induced suppression of contact hypersensitivity to the recall antigen nickel sulfate in human skin. Free Radic Biol Med 1999; 27:422-7.
25. Thanos SM, Halliday GM, Damian DL. Nicotinamide reduces photodynamic therapy-induced immunosuppression in humans. Br J Dermatol 2012;167:631-6.
26. Wallingford SC, Pilkington SM, Massey KA, Al-Asswaad NMI, Ibiebele TI, Hughes MC, Bennett S, Nicolaou A, Rhodes LE, Green AC. Threeway assessment of long chain omega-3 PUFA nutrition: by questionnaire and matched blood and skin samples. Br J Nutr (Epub ahead of print 23 May 2012).
27. Memon AA, Friedmann PS. Studies on the reproducibility of allergic contact dermatitis. Br J Dermatol 1996;134:208-14.
28. Green P, Anyakoha N, Yadid G, Gispan-Herman I, Nicolaou A. Arachidonic acid-containing phosphatidylcholine species are increased in selected brain regions of a depressive animal model: implications for pathophysiology. Prostaglandins Leukot Essent Fatty Acids 2009;80: 213-20.
29. Scientific Advisory Committee on Nutrition (SACN). Advice on fish consumption: benefits and risks. London, United Kingdom: The Stationary Office, 2004.
30. Bonamonte D, Foti C, Antelmi AR, Biscozzi AM, Naro ED, Fanelli M, Loverro G, Angelini G. Nickel contact allergy and menstrual cycle. Contact Dermatitis 2005;52:309-13.
31. Moison RM, Steenvoorden DP, Beijersbergen van Henegouwen GM. Topically applied eicosapentaenoic acid protects against local immunosuppression induced by UVB irradiation, cis-urocanic acid and thymidine dinucleotides. Photochem Photobiol 2001;73:64-70.
32. Black HS, Rhodes LE. The potential of omega-3 fatty acids in the prevention of non-melanoma skin cancer. Cancer Detect Prev 2006;30: 224-32.
33. Kelly DA, Seed PT, Young AR, Walker SL. A commercial sunscreen's protection against ultraviolet radiation-induced immunosuppression is more than 50% lower than protection against sunburn in humans. J Invest Dermatol 2003;120:65-71.
34. Diffey B. Sunscreen isn't enough. J Photochem Photobiol B 2001;64: 105-8.
35. Bech-Thomsen N, Wulf HC. Sunbathers' application of sunscreen is probably inadequate to obtain the sun protection factor assigned to the preparation. Photodermatol Photoimmunol Photomed 1992-1993;9: 242-4.
36. Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, et al. Effect of n23 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebocontrolled trial. Lancet 2008;372:1223-30.
37. Metherel AH, Armstrong JM, Patterson AC, Stark KD. Assessment of blood measures of n23 polyunsaturated fatty acids with acute fish oil supplementation and washout in men and women. Prostaglandins Leukot Essent Fatty Acids 2009;81:23-9.
38. Pilkington SM, Watson RE, Nicolaou A, Rhodes LE. Omega-3 polyunsaturated fatty acids: photoprotective macronutrients. Exp Dermatol 2011;20:537-43.
39. Gibney MJ, Hunter B. The effects of short-and long-term supplementation with fish oil on the incorporation of n23 polyunsaturated fatty acids into cells of the immune system in healthy volunteers. Eur J Clin Nutr 1993;47:255-9.
40. Rhodes LE, Gledhill K, Masoodi M, Haylett AK, Brownrigg M, Thody AJ, Tobin DJ, Nicolaou A. The sunburn response in human skin is characterized by sequential eicosanoid profiles that may mediate its early and late phases. FASEB J 2009;23:3947-56.
41. Tripp CS, Blomme EA, Chinn KS, Hardy MM, LaCelle P, Pentland AP. Epidermal COX-2 induction following ultraviolet irradiation: suggested mechanism for the role of COX-2 inhibition in photoprotection. J Invest Dermatol 2003;121:853-61.
42. Nijsten T, Colpaert CG, Vermeulen PB, Harris AL, Van Marck E, Lambert J. Cyclooxygenase-2 expression and angiogenesis in squamous cell carcinoma of the skin and its precursors: a paired immunohistochemical study of 35 cases. Br J Dermatol 2004;151:837-45.
43. Rundhaug JE, Fischer SM. Cyclo-oxygenase-2 plays a critical role in uv-induced skin carcinogenesis. Photochem Photobiol 2008;84:322-9.
44. Reeve VE, Matheson M, Greenoak GE, Canfield PJ, Boehm-Wilcox C, Gallagher CH. Effect of dietary lipid on UV light carcinogenesis in the hairless mouse. Photochem Photobiol 1988;48:689-96.
45. Rheins LA, Barnes L, Amornsiripanitch S, Collins CE, Nordlund JJ. Suppression of the cutaneous immune response following topical application of the prostaglandin PGE2. Cell Immunol 1987;106:33-42.
46. Rhodes LE, Durham BH, Fraser WD, Friedmann PS. Dietary fish oil reduces basal and ultraviolet B-generated PGE2 levels in skin and increases the threshold to provocation of polymorphic light eruption. J Invest Dermatol 1995;105:532-5.
47. Shreedhar V, Giese T, Sung VW, Ullrich SE. A cytokine cascade including prostaglandin E2, IL-4, and IL-10 is responsible for UVinduced systemic immune suppression. J Immunol 1998;160:3783-9.
48. Kali-nski P, Hilkens CM, Snijders A, Snijdewint FG, Kapsenberg ML. Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses. Adv Exp Med Biol 1997; 417:363-7.
49. Shahbakhti H, Watson RE, Azurdia RM, Ferreira CZ, Garmyn M, Rhodes LE. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin26 and interleukin-8 in human skin in vivo. Photochem Photobiol 2004;80:231-5.
50. Hart PH, Jaksic A, Swift G, Norval M, el-Ghorr AA, Finlay-Jones JJ. Histamine involvement in UVB-and cis-urocanic acid-induced systemic suppression of contact hypersensitivity responses. Immunology 1997;91:601-8.
51. Elmets CA, Viner JL, Pentland AP, Cantrell W, Lin H-Y, Bailey H, Kang S, Linden KG, Heffernan M, Duvic M, et al. Chemoprevention of nonmelanoma skin cancer with celecoxib: a randomized, double-blind, placebo-controlled trial. J Natl Cancer Inst 2010;102:1835-44.
52. Fischer SM, Lo HH, Gordon GB, Seibert K, Kelloff G, Lubet RA, Conti CJ. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis. Mol Carcinog 1999;25:231-40.
53. Orengo IF, Gerguis J, Phillips R, Guevara A, Lewis AT, Black HS. Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model. Arch Dermatol 2002;138:751-5.
54. González Maglio DH, Paz ML, Ferrari A, Weill FS, Nieto J, Leoni J. Alterations in skin immune response throughout chronic UVB irradiationskin cancer development and prevention by naproxen. Photochem Photobiol 2010;86:146-52.
55. Süleyman H, Demircan B, Karagoz Y. Anti-inflammatory and side effects of cyclooxygenase inhibitors. Pharmacol Rep 2007;59:247-58.
56. Bays HE. Safety considerations with omega-3 fatty acid therapy. Am J Cardiol 2007;99:35C-43C.
57. Friedmann PS. The relationships between exposure dose and response in induction and elicitation of contact hypersensitivity in humans. Br J Dermatol 2007;157:1093-102.